Metlife Stock Earnings Reports

MetLife reported an excellent start to 2026, driven by broad-based top-line growth, resilient margins and disciplined capital deployment under its New Frontier strategy. First‑quarter adjusted earnings were $1.6 billion ($2.42 per share), up 18% year‑over‑year (adjusted EPS +23%). Adjusted return on equity was 17%, at the top end of the company's 15%–17% target range. Variable investment income (VII) was strong at $518 million pretax, led by private equity returns. All major operating segments showed growth: Group Benefits (+19% adjusted earnings) with very favorable working‑age mortality and strong sales; Retirement & Income Solutions (+11%) supported by VII and diverse reinsurance/PRT activity; Asia (+31%) with particularly strong Japan and Korea results; Latin America and EMEA also delivered growth. MetLife Investment Management (MIM) posted its first fully integrated quarter after the PineBridge acquisition (adjusted earnings $47 million) with a solid pipeline despite modest near‑term outflows. The company emphasized disciplined expense management (direct expense ratio 11.9%, ahead of 2026 target), continued AI/tech investments, a high‑quality private assets portfolio, and strong liquidity/capital actions: ~$750M share repurchases and ~$370M dividends in Q1, an April incremental ~$200M buyback, $1.1B remaining on the authorization, and a 4.4% dividend increase. Management noted ongoing regulatory engagement in Japan, the divestiture of Ukraine operations, and an opportunistic $1B subordinated debt issuance. Outlook commentary: management is confident in the full‑year targets (RIS full‑year range reiterated) and expects continued execution, with spreads and VII tracking to guidance and capital generation remaining strong.